Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 75-84, January 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Ines, C.
Right arrow Articles by Temple, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Ines, C.
Right arrow Articles by Temple, C., Jr.

Inhibition of Microtubules and Cell Cycle Arrest by a New 1-Deaza-7,8-dihydropteridine Antitumor Drug, CI 980, and by Its Chiral Isomer, NSC 6138631

Concepcion de Ines, Daniel Leynadier, Isabel Barasoain2, Vincent Peyrot, Patrick Garcia, Claudette Briand, Gregory A. Rener and Carroll Temple, Jr.

Centro de Investigaciones Biologicas, Consejo Superior de Investigaciones Cientificas, Velazquez 144, 28006 Madrid, Spain [C. I., L B.]; Groupe de Recherche sur les Interactions des Proteines en Pharmacologie, Faculté de Pharmacie, 27Bd. Jean Moulin, 13385 Marseille Cedex 5, France [D. L., V. P., P. G., C. B.]; and Organic Chemistry Research Department, Southern Research Institute, Birmingham, Alabama [G. A. R., C. T.]

2 To whom requests for reprints should be addressed.

CI 980 (NSC 613862; [S-(–)]) and NSC 613863 [R-(+)] are the two chiral isomers of ethyl 5-amino l,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 370147), which is a mitotic inhibitor with in vivo and in vitro activity against murine multidrug-resistant sublines. We have characterized the inhibition of in vitro microtubule assembly by the S (CI 980) and R (NSC 613863) enantiomers, their actions on the cytoplasmic microtubule network of epithelial-like PtK2 cells, and on the cell cycle of different human and murine leukemias and PtK2 cells. Assembly of purified tubulin, or tubulin plus microtubule-associated proteins, into microtubules was substoichiometrically inhibited by both compounds, which also induced a slow depolymerization of preassembled microtubules. Half inhibitory concentrations were 0.4–0.7 µM and 1.6–2.1 µM for the S and R isomers, respectively. Excess of both drugs induced polymerization of liganded tubulin into abnormal polymers similar to colchicine. The cytoplasmic microtubules of PtK2 cells were disrupted by both compounds in a concentration- and time-dependent manner, which was observed by indirect immunofluorescence microscopy and quantified by an enzyme-linked immunoassay of cytoskeletal tubulin. Half inhibitory concentrations were 6 nM S isomer, 100 nM R isomer, and 1 µM colchicine. Twenty nM S isomer or 500–700 nM R isomer gave nearly maximal effect. At these concentrations, half maximal microtubule depolymerization took place after 2 h of treatment. After drug removal, slow microtubule assembly and nearly complete reorganization of the cytoplasmic microtubules of PtK2 cells were observed (24 h). One nM S enantiomer or 25 nM R enantiomer induced mitotic arrest in 8 h in U937, HL60, and EL4 leukemias. PtK2 cells also stopped in mitosis after a 24-h incubation with 50 nM R isomer or S nM S isomer. The inhibition of cell division was irreversible in the leukemic cells, while PtK2 cells partially resumed growth. Although the interactions of CI 980 with microtubules in vitro are not very different from other drugs, it is a most potent cellular microtubule and mitotic inhibitor.

1 This work was supported by Grant PB 87-0230 from the Direccion General de Investigacion Cientifica y Tecnica, French-Spanish grants, and grants from Association pour la Recherche sur le Cancer Federation de Centres de lutte Contre Cancer.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 7/16/93. Accepted 10/29/93.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. F. Diaz, I. Barasoain, A. A. Souto, F. Amat-Guerri, and J. M. Andreu
Macromolecular Accessibility of Fluorescent Taxoids Bound at a Paclitaxel Binding Site in the Microtubule Surface
J. Biol. Chem., February 4, 2005; 280(5): 3928 - 3937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. F. Diaz, I. Barasoain, and J. M. Andreu
Fast Kinetics of Taxol Binding to Microtubules. EFFECTS OF SOLUTION VARIABLES AND MICROTUBULE-ASSOCIATED PROTEINS
J. Biol. Chem., February 28, 2003; 278(10): 8407 - 8419.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Beckers, T. Reissmann, M. Schmidt, A. M. Burger, H. H. Fiebig, U. Vanhoefer, H. Pongratz, H. Hufsky, J. Hockemeyer, M. Frieser, et al.
2-Aroylindoles, a Novel Class of Potent, Orally Active Small Molecule Tubulin Inhibitors
Cancer Res., June 1, 2002; 62(11): 3113 - 3119.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Gajate, I. Barasoain, J. M. Andreu, and F. Mollinedo
Induction of Apoptosis in Leukemic Cells by the Reversible Microtubule-disrupting Agent 2-Methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: Protection by Bcl-2 and Bcl-XL and Cell Cycle Arrest
Cancer Res., May 1, 2000; 60(10): 2651 - 2659.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. D. Smith and X. Zhang
Mechanism of Action of Cryptophycin
J. Biol. Chem., March 15, 1996; 271(11): 6192 - 6198.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.